Target intelligence / Profile preview

Staphylococcus aureus (S. aureus) (S. aureus)

Target
S. aureus
Molecular classification
Gram-positive bacteria, Bacillota, Staphylococcaceae
01

Overview

Staphylococcus aureus is a Gram-positive, round-shaped bacterium that is a common member of the human microbiota, typically colonizing the skin and nares [StatPearls: Staphylococcus Aureus]. While often harmless, it is a versatile pathogen capable of causing a wide spectrum of diseases, from superficial skin abscesses to life-threatening systemic infections such as endocarditis, osteomyelitis, and sepsis [CDC: Staph Infections]. Susceptible strains, often referred to as Methicillin-Susceptible Staphylococcus aureus (MSSA), lack the mecA gene and remain sensitive to beta-lactamase-resistant penicillins and other standard antibiotics [Nature Reviews Microbiology: Staphylococcus aureus]. The pathogenicity of S. aureus is driven by an extensive repertoire of virulence factors, including surface proteins for adhesion, enzymes that degrade host tissues, and toxins that disrupt host cell membranes or trigger massive immune responses [PubMed: Antibiotic mechanisms of action]. Therapeutic intervention focuses on targeting essential bacterial components, such as the cell wall, ribosomes, or DNA replication machinery, to achieve bactericidal or bacteriostatic effects [StatPearls: Staphylococcus Aureus].

Other names
S. aureusGolden staphMSSAMethicillin-susceptible Staphylococcus aureus
02

Mechanism of action

Antibiotics targeting susceptible S. aureus act through various mechanisms: beta-lactams and glycopeptides inhibit cell wall peptidoglycan synthesis; macrolides, lincosamides, and oxazolidinones inhibit protein synthesis at the ribosome; and lipopeptides disrupt the bacterial cell membrane integrity.

03

Biological functions

ColonizationPathogenesisToxin productionBiofilm formationImmune evasion
04

Disease associations

InfectionSkin and soft tissue infectionPneumoniaEndocarditisBacteremiaOsteomyelitisSepsisToxic shock syndrome
05

Safety considerations

Antimicrobial resistance developmentHypersensitivity reactions to beta-lactamsGastrointestinal dysbiosisRisk of Clostridioides difficile infectionDrug-specific toxicities (e.g., nephrotoxicity with vancomycin)
06

Interacting drugs

Nafcillin

8 more in the full profile.

07

Biomarkers

Coagulase positivityCatalase positivityProtein A (spa gene)Nuc (nuclease) geneAlpha-hemolysin

Beyond the preview

Go deeper on Staphylococcus aureus (S. aureus) (S. aureus).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus aureus (S. aureus) (S. aureus).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call